The pathomechanistic connection between autism and myotonic muscular dystrophy type 1.
Takeda wins label expansion for subcutaneous Entyvio, creating ‘flexibility’ for Crohn’s patients
Patients taking Takeda’s Entyvio for Crohn’s disease will now have the option of a subcutaneous version. Takeda announced the label expansion on Friday, several months